Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for AF- 2
Most Correlated Studies
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Most Relevant Literature
- Distinct Regions of the Haloferax volcanii Dolichol Phosphate-Mannose Synthase AglD Mediate the Asse…
- Probiotic potential and wound-healing activity of Pediococcus pentosaceus strain AF2 isolated from H…
- Carcinogenic risk of food additive AF-2 banned in Japan: a case study on reassessment of genotoxicit…
- Intensive heart rhythm monitoring to decrease ischemic stroke and systemic embolism-the Find-AF 2 st…
- Deciphering the relational dynamics of AF-2 domain of PAN PPAR through drug repurposing and comparat…
Most Relevant Clinical Trials
- Intensive Rhythm Monitoring to Decrease Ischemic Stroke and Systemic Embolism - the Find-AF 2 Study
- A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Wi…
- Redo AF Sub Study (of the Pure EP 2.0 Main Study)
- WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2
- Phase 2 Study of Oral K201 for Prevention of AF Recurrence
